# A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

> **NCT06892548** · PHASE1,PHASE2 · RECRUITING · sponsor: **BioNTech SE** · enrollment: 594 (estimated)

## Conditions studied

- Advanced Lung Cancer

## Interventions

- **BIOLOGICAL:** BNT324
- **BIOLOGICAL:** BNT327

## Key facts

- **NCT ID:** NCT06892548
- **Lead sponsor:** BioNTech SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-02
- **Primary completion:** 2027-08
- **Final completion:** 2031-06
- **Target enrollment:** 594 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06892548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06892548, "A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06892548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*